Business Description
INVO Bioscience Inc
NAICS : 339112
SIC : 3841
ISIN : US44984F1049
Description
INVO Bioscience Inc operates a healthcare services fertility company. Assisted Reproductive Technology (ART) marketplace by making fertility care more accessible and inclusive to people. Its commercial strategy is focused on operating fertility-focused clinics, which includes the opening of dedicated INVO Centers offering the INVOcell and IVC procedure (with three centers in North America now operational) and the acquisition of US-based, profitable in vitro fertilization (IVF) clinics. The company sells its products to physicians directly; and IVF centers, medical practices, and physicians through distributors.
Financial Strength
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.03 | |||||
| Equity-to-Asset | 0.04 | |||||
| Debt-to-Equity | 9.72 | |||||
| Debt-to-EBITDA | -1.27 | |||||
| Piotroski F-Score | 3/9 | |||||
| Altman Z-Score | -5.17 | |||||
| Beneish M-Score | -0.9 | |||||
| WACC vs ROIC | ||||||
Growth Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -20.1 | |||||
| 3-Year EBITDA Growth Rate | 39.6 | |||||
| 3-Year EPS without NRI Growth Rate | 45.2 | |||||
| 3-Year FCF Growth Rate | 42.8 |
Momentum Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 37.4 | |||||
| 9-Day RSI | 44.6 | |||||
| 14-Day RSI | 46.85 | |||||
| 6-1 Month Momentum % | -26.81 | |||||
| 12-1 Month Momentum % | -86.64 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 0.15 | |||||
| Quick Ratio | 0.12 | |||||
| Cash Ratio | 0.03 | |||||
| Days Inventory | 54.19 | |||||
| Days Sales Outstanding | 12.32 | |||||
| Days Payable | 374.14 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -72.9 | |||||
| Shareholder Yield % | -368.96 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 40.52 | |||||
| Operating Margin % | -223.97 | |||||
| Net Margin % | -265.97 | |||||
| FCF Margin % | -157.37 | |||||
| ROA % | -70.16 | |||||
| ROIC % | -51.33 | |||||
| ROC (Joel Greenblatt) % | -158.93 | |||||
| ROCE % | -111.23 |
GF Value Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 0.54 | |||||
| EV-to-EBIT | -2.42 | |||||
| EV-to-EBITDA | -2.51 | |||||
| EV-to-Revenue | 5.67 | |||||
| EV-to-Forward-Revenue | 0.68 | |||||
| EV-to-FCF | -3.61 | |||||
| Earnings Yield (Greenblatt) % | -41.32 | |||||
| FCF Yield % | -176.93 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:INVO
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
INVO Bioscience Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 3.021 | ||
| EPS (TTM) ($) | -8.56 | ||
| Beta | 2.91 | ||
| Volatility % | 137.03 | ||
| 14-Day RSI | 46.85 | ||
| 14-Day ATR ($) | 0.276898 | ||
| 20-Day SMA ($) | 1.035755 | ||
| 12-1 Month Momentum % | -86.64 | ||
| 52-Week Range ($) | 0.5 - 10.498 | ||
| Shares Outstanding (Mil) | 2.74 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
INVO Bioscience Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
INVO Bioscience Inc Stock Events
| Event | Date | Price($) | ||
|---|---|---|---|---|
| No Event Data | ||||
INVO Bioscience Inc Frequently Asked Questions
What is INVO Bioscience Inc(INVO)'s stock price today?
The current price of INVO is $0.98. The 52 week high of INVO is $10.50 and 52 week low is $0.50.
When is next earnings date of INVO Bioscience Inc(INVO)?
The next earnings date of INVO Bioscience Inc(INVO) is 2024-05-15 Est..
Does INVO Bioscience Inc(INVO) pay dividends? If so, how much?
INVO Bioscience Inc(INVO) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers